Mapping of Incontinence Quality of Life (I-QOL) scores to Assessment of Quality of Life 8D (AQoL-8D) utilities in patients with idiopathic overactive bladder

Assessment of treatment-seeking behavior and healthcare utilization in an international cohort of subjects with overactive bladder

(2014) Miguel Jimenez-Cidre et al.   CURRENT MEDICAL RESEARCH AND OPINION

From KIDSCREEN-10 to CHU9D: creating a unique mapping algorithm for application in economic evaluation

(2014) Gang Chen et al.   Health and Quality of Life Outcomes

OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

(2013) Christopher Chapple et al.   EUROPEAN UROLOGY

Mapping EQ-5D Utility Scores from the Incontinence Quality of Life Questionnaire among Patients with Neurogenic and Idiopathic Overactive Bladder

(2013) Stephen Kay et al.   VALUE IN HEALTH

OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial

(2012) Victor W. Nitti et al.   JOURNAL OF UROLOGY

Predicting EQ-5D Values Using the SGRQ

(2011) Helen J. Starkie et al.   VALUE IN HEALTH

Mapping onto Eq-5 D for patients in poor health

(2010) Matthijs M Versteegh et al.   Health and Quality of Life Outcomes

Mixed Urinary Incontinence: Greater Impact on Quality of Life

(2009) Anna C. Frick et al.   JOURNAL OF UROLOGY